Aclaris Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: Aclaris Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Aclaris Therapeutics Inc
Rating: 2.13175
Author: Trendlyne DVM scores

about

Aclaris Therapeutics Inc is a clinical-stage biopharmaceutical company. It focuses on developing novel drug candidates for immuno-inflammatory diseases using its proprietary KINect drug discovery platform. The company's pipeline consists of the follo...

4.80 -0.29 (-5.70%)

New 52W High today

2.2M

XNAS Volume

XNAS 14 May, 2026 5:30 PM (EDT)

Not Eligible

Expensive Valuation

6.5 / 100

Technically Bullish

78.8 / 100

1Yr Price target upside is 101%

9 analysts

Aclaris Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Aclaris Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Aclaris Therapeutics Inc is a clinical-stage biopharmaceutical company. It focuses on developing novel drug candidates for immuno-inflammatory diseases using its proprietary KINect drug discovery platform. The company's pipeline consists of the follo...

New 52W High today

SWOT Analysis

Aclaris Therapeutics Inc Live Price Chart